Park Young Eun, Lee Jae Hoon, Yun Woo-Sung, Park Ki Hyuk
Division of Vascular Surgery, Department of Surgery, Daegu Catholic University College of Medicine, Daegu, Korea.
Department of Surgery, Yeungnam University, College of Medicine, Daegu, Korea.
J Korean Med Sci. 2014 Dec;29(12):1678-83. doi: 10.3346/jkms.2014.29.12.1678. Epub 2014 Nov 21.
Endovascular salvage of the hypogastric artery using iliac branch device (IBD) during endovascular aortic aneurysm repair (EVAR), offers less invasive alternative solution to surgery to prevent pelvic ischemia. We have performed the first Korean surgeon custom-made IBD for this purpose to overcome the limitation of unavailability of the devices in Korea. Four patients with abdominal aortic aneurysm with bilateral common iliac artery aneurysm (CIAA) were treated using custom-made IBDs from October 2013 to December 2013. IBD was created in back table before EVAR operation using TFLE Zenith iliac limb stent graft (Cook Inc.). Three V12 (Atrium, Inc.) one Viabahn (Gore, Inc.) were used for bridging between IBD and target hypogastric artery. With this modification of IBD procedure, exteriorize the guide wire without snare device is possible which offers another benefit in terms of reducing medical costs comparing to commercial IBD. All operations were successful without any device related complications or postoperative endoleaks. During the mean follow up of 3 months, all IBD were patent without clinical complications. Surgeon custom made IBD is feasible and useful to preserve pelvic perfusion especially in the situation of limited commercial IBD availability in many countries. Long-term follow-up is needed to evaluate stent graft patency and IBD-related complications.
在血管内主动脉瘤修复术(EVAR)期间,使用髂支装置(IBD)对下腹动脉进行血管内挽救,为预防盆腔缺血提供了侵入性较小的手术替代方案。为克服韩国无法获得该装置的局限性,我们首次为此目的进行了韩国外科医生定制的IBD。2013年10月至2013年12月,对4例患有双侧髂总动脉瘤(CIAA)的腹主动脉瘤患者使用定制的IBD进行了治疗。IBD在EVAR手术前在体外使用TFLE Zenith髂支支架移植物(Cook公司)制作。3个V12(Atrium公司)和1个Viabahn(戈尔公司)用于IBD与目标下腹动脉之间的桥接。通过对IBD手术的这种改进,无需圈套装置即可引出导丝,与商用IBD相比,这在降低医疗成本方面提供了另一个好处。所有手术均成功,无任何与装置相关的并发症或术后内漏。在平均3个月的随访期间,所有IBD均通畅,无临床并发症。外科医生定制的IBD对于保留盆腔灌注是可行且有用的,尤其是在许多国家商用IBD供应有限的情况下。需要进行长期随访以评估支架移植物的通畅性和与IBD相关的并发症。